EULAR 2022

Updated EULAR RA recommendations: does it change the status of JAKies?

The road of glucocorticoids in RA

Prevention of RA possible by treating very early?

Rapid tapering of steroids - how quickly should we taper the patient?

The significance of depression and air pollution in patients with RA

Double-blind placebo controlled trial of MTX in patients with arthralgia at risk for RA

Analysis of baseline ORAL surveillance data: is it due to patient history and geography?

HOT - Difficulties in treatment of RA

Interest of methotrexate before the emergence of RA

Can early abatacept therapy in high-risk patients prevent onset of RA?

Does MTX have a disease modifying effect in patients with arthralgia?

Risk of venous thromboembolic events in ORAL Surveillance study

Radiographic progression in RA patients in daily practice is independent of stringent T2T strategy

Betydning av depresjon og luftforurensning hos pasienter med revmatiske sykdommer

Interet du méthotrexate avant l´émergence de la PR

Liegt es an Vorgeschichte und oder Geographie?

Abordaje de la artritis reumatoide difícil de tratar

Frühzeitige Abatacept-Therapie bei Hochrisiko RA präventiv?

Riesgo de eventos tromboembolicos en el ORAL Surveillance

Radiologische Progression ist unabhängig von stringenter T2T-Strategie

Har MTX en sykdomsmodifiserende effekt hos pasienter med leddsmerter og subklinisk leddinflammasjon?

Metotrexate en pacientes con artralgia inflamatoria en riesgo de evolución a artritis reumatoide un ensayo​Dear Sara doble ciego

MRT auch ohne Kontrastmittel bei RA einsetzbar

New data on IL-17 inhibition and a 1st in class molecule

The (unmet) need for perspective biomarkers in SpA

Hot topic spine: axial diseases in SpA and suitable activity scores

A new treatment for PsA

Course of ultrasound-detected synovitis in PsA patients receiving secukinumab

Low rates of sustained remission in a real world setting in PsA patients

PsA is associated with a higher risk of hematological malignancies

Who has the best chance of being in prolonged remission in psoriasis arthritis?

Revival of leflunomide - the combination with MTX

First in class: new molecule to inhibit IL-17A

Every joint counts! Even patients with LJC should be treated to target

Guselkumab "more safe" than Placebo

New therapies for PsA

Guselkumab "sicherer" als Plazebo

Jedes Gelenk zählt! Auch bei niedrigem Joint Count Treat-to-Target

Neues Molekül zur Hemmung von IL-17A

Novità nel trattamento dell’Artrite Psoriasica

Verlauf von sonographischer Synovitis unter Secukinumab

Geringe Raten an anhaltender Remission im Real Wold Setting

PsA mit einem höheren Risiko für hämatologische Malignitäten assoziiert?

Revival von Leflunomid - in Kombination mit MTX

Qui a le plus de chance d´etre en rémission prolongee dans le rhumatisme psoriasique?

New ASAS/EULAR axSpA recommendations

New drugs in axSpA

Artificial intelligence in axSpA

A deep dive review of axSpA

Rates of progression from non-radiographic to radiographic axSpA

Nuevos terapias en EspAax

Inteligencia artificial en EspAax

Rivisitazione dell’impegno assiale dell'artrite psoriasica

Percentuale di progressione da forma non radiografica a radiografica di AxSpA

Nuevos recomendaciones ASAS/EULAR en EspAax

Voclosporin for Lupus Nephritis

Deucravacitinib for Lupus Erythematosus - Phase II study

Voclosporin bei Lupus Nephritis

TYK2-Inhibitor Deucravacitinib wirksam und verträglich

Predictive severity factors of COVID-19 in R-IMID patients

Type of mRNA COVID-19 vaccine influences antibody kinetics

Vaccination in rheumatic diseases including COVID-19

Vaccination response against COVID-19 in patients with immune-mediated inflammatory diseases

Antikörperkinetik unter verschiedenen mRNA-COVID-19-Impfstoffen

Vaksine respons (COVID-19) hos pasienter med immunmedierte inflammatoriske sykdommer

GM-CSF is increased in patients with AS and persists despite anti-TNF treatment

I livelli di GM-CSF sono incrementati nei pazienti con AS e non modulati dal trattamento con anti-TNF

Management of calcific tendonitis by BARBOTAGE

Link between biomechanical stretch and synovial inflammation

Real-world data of an etanercept biosimilar (GP2015) in rheumatic diseases

New developments in the field of osteoarthristis

The microbiota to predict the response to the treatment of psoriasis arthritis

Pain - challenges in clinical practice

Legame tra stress biomeccanico e infiammazione sinoviale

Le microbiote pour prédire la réponse au traitement du rhumatisme psoriasique